$GDLG
Glidelogic Corp.

2024 Q2 Form 10-Q Financial Statement

#000109690624001373 Filed on June 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q2
Revenue $32.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $32.00
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $6.890K
YoY Change
% of Gross Profit 21531.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $105.00 $105.00
YoY Change 0.0% -91.46%
% of Gross Profit 328.13%
Operating Expenses $6.891K $8.750K
YoY Change -21.25% 141.05%
Operating Profit -$6.859K -$8.750K
YoY Change -21.61% 141.05%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$6.860K
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$6.859K -$8.750K
YoY Change -21.61% 141.05%
Net Earnings / Revenue -21434.38%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 66.59M shares 2.664M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $890.00 $5.900K
YoY Change -84.92%
Cash & Equivalents $893.00 $5.902K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $893.00 $5.902K
YoY Change -84.87%
LONG-TERM ASSETS
Property, Plant & Equipment $3.228K $3.648K
YoY Change -11.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.228K $3.648K
YoY Change -11.51%
TOTAL ASSETS
Total Short-Term Assets $893.00 $5.902K
Total Long-Term Assets $3.228K $3.648K
Total Assets $4.121K $9.550K
YoY Change -56.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.37K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $8.450K $6.010K
YoY Change 40.6%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.81K $6.010K
YoY Change 246.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $20.81K $6.010K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $20.81K $6.010K
YoY Change 246.26%
SHAREHOLDERS EQUITY
Retained Earnings -$83.29K -$25.01K
YoY Change 233.01%
Common Stock $66.59K $2.664K
YoY Change 2399.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$16.69K $3.540K
YoY Change
Total Liabilities & Shareholders Equity $4.121K $9.550K
YoY Change -56.85%

Cashflow Statement

Concept 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$6.859K -$8.750K
YoY Change -21.61% 141.05%
Depreciation, Depletion And Amortization $105.00 $105.00
YoY Change 0.0% -91.46%
Cash From Operating Activities $29.00 -$8.645K
YoY Change -100.34% 9.43%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $665.00 $0.00
YoY Change
NET CHANGE
Cash From Operating Activities $29.00 -$8.645K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $665.00 $0.00
Net Change In Cash $694.00 -$8.645K
YoY Change -108.03%
FREE CASH FLOW
Cash From Operating Activities $29.00 -$8.645K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 dei Document Type
DocumentType
10-Q
CY2024Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q2 dei Document Period End Date
DocumentPeriodEndDate
2024-04-30
CY2024Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 dei Entity File Number
EntityFileNumber
333-254750
CY2024Q2 dei Entity Registrant Name
EntityRegistrantName
GLIDELOGIC CORP.
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-16693 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-9834 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4121 usd
CY2024Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1575837
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
11264 Playa Court
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Culver City
CY2024Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90230
CY2024Q2 dei City Area Code
CityAreaCode
310
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
397-2300
CY2024Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
66593750 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
893 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199 usd
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
0 usd
CY2024Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1416 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
893 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1615 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3228 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3333 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
3228 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
3333 usd
CY2024Q2 us-gaap Assets
Assets
4121 usd
CY2024Q1 us-gaap Assets
Assets
4948 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12365 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
9782 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2024Q1 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2024Q2 us-gaap Loans Payable
LoansPayable
5000 usd
CY2024Q1 us-gaap Loans Payable
LoansPayable
5000 usd
CY2024Q2 fil Note Payable To Ma
NotePayableToMa
500 usd
CY2024Q1 fil Note Payable To Ma
NotePayableToMa
0 usd
CY2024Q2 fil Note Payable To Xue
NotePayableToXue
165 usd
CY2024Q1 fil Note Payable To Xue
NotePayableToXue
0 usd
CY2024Q2 fil Sli Loan Payable
SliLoanPayable
2784 usd
CY2024Q1 fil Sli Loan Payable
SliLoanPayable
0 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
20814 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14782 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66593750 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66593750 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
66594 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
66594 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-83287 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-76428 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4948 usd
CY2024Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
32 usd
CY2023Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
0 usd
CY2024Q2 us-gaap Revenues
Revenues
32 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
32 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6891 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8750 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
6891 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
8750 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6859 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8750 usd
CY2024Q2 us-gaap Other Income
OtherIncome
0 usd
CY2023Q2 us-gaap Other Income
OtherIncome
0 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-6859 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8750 usd
CY2024Q2 fil Net Loss Basic And Diluted
NetLossBasicAndDiluted
-0
CY2023Q2 fil Net Loss Basic And Diluted
NetLossBasicAndDiluted
-0
CY2024Q2 fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
66593750 shares
CY2023Q2 fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
66593750 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12290 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8750 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3540 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-9834 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-6859 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-16693 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-6859 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8750 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2583 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 usd
CY2024Q2 us-gaap Depreciation
Depreciation
105 usd
CY2023Q2 us-gaap Depreciation
Depreciation
105 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1416 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
CY2024Q2 fil Increase Decrease In Sli Loan Payable
IncreaseDecreaseInSliLoanPayable
-2784 usd
CY2023Q2 fil Increase Decrease In Sli Loan Payable
IncreaseDecreaseInSliLoanPayable
0 usd
CY2024Q2 fil Total Adjustments To Reconcile Net Loss To Net Cash Provided By Operations
TotalAdjustmentsToReconcileNetLossToNetCashProvidedByOperations
-6888 usd
CY2023Q2 fil Total Adjustments To Reconcile Net Loss To Net Cash Provided By Operations
TotalAdjustmentsToReconcileNetLossToNetCashProvidedByOperations
-105 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8645 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024Q2 fil Increase Decrease In Note Payable To Ma
IncreaseDecreaseInNotePayableToMa
500 usd
CY2023Q2 fil Increase Decrease In Note Payable To Ma
IncreaseDecreaseInNotePayableToMa
0 usd
CY2024Q2 fil Increase Decrease In Note Payable To Xue
IncreaseDecreaseInNotePayableToXue
165 usd
CY2023Q2 fil Increase Decrease In Note Payable To Xue
IncreaseDecreaseInNotePayableToXue
0 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
665 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
694 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8645 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
199 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14547 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
893 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5902 usd
CY2024Q2 us-gaap Interest Paid
InterestPaid
0 usd
CY2023Q2 us-gaap Interest Paid
InterestPaid
0 usd
CY2024Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><b>Use of Estimates</b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.</p>
CY2024Q2 fil Nonmonetary Exchange Invoice Amount
NonmonetaryExchangeInvoiceAmount
30000 usd
CY2024Q2 fil Nonmonetary Exchange Invoice Amount
NonmonetaryExchangeInvoiceAmount
30000 usd
CY2024Q2 fil Total Loan Offset Amounts
TotalLoanOffsetAmounts
-30000 usd
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
0 usd
CY2024Q2 fil Nonmonetary Exchange Invoice Amount
NonmonetaryExchangeInvoiceAmount
30000 usd
CY2024Q2 fil Total Loan Offset Amounts
TotalLoanOffsetAmounts
-30000 usd
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
0 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4453 usd
CY2024Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2024Q2 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4453 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1120 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
-105 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1225 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3228 usd
CY2024Q2 fil Sli Loan Payable Payoff
SliLoanPayablePayoff
-4200 usd
CY2024Q2 fil Sli Loan Payable Payoff
SliLoanPayablePayoff
-4200 usd
CY2024Q2 fil Paid By A Portion Of The Nonmonetary Exchange Invoice Amount From Ar
PaidByAPortionOfTheNonmonetaryExchangeInvoiceAmountFromAR
-1416 usd
CY2024Q2 fil Sli Loan Payable Payoff Net
SliLoanPayablePayoffNet
2784 usd
CY2024Q2 fil Sli Loan Payable
SliLoanPayable
2784 usd
CY2024Q2 fil Sli Loan Payable
SliLoanPayable
2784 usd
CY2024Q2 fil Increase Decrease In Note Payable To Ma
IncreaseDecreaseInNotePayableToMa
500 usd
CY2024Q2 fil Note Payable To Ma
NotePayableToMa
500 usd
CY2024Q2 fil Note Payable To Ma
NotePayableToMa
500 usd
CY2024Q2 fil Increase Decrease In Note Payable To Xue
IncreaseDecreaseInNotePayableToXue
165 usd
CY2024Q2 fil Note Payable To Xue
NotePayableToXue
165 usd
CY2024Q2 fil Note Payable To Xue
NotePayableToXue
165 usd
CY2024Q2 us-gaap Loans Payable
LoansPayable
5000 usd
CY2024Q2 us-gaap Loans Payable
LoansPayable
5000 usd
CY2024Q2 us-gaap Loans Payable
LoansPayable
5000 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2000 usd
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3218750 shares
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5150 usd
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
9468750 shares
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15150 usd
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3906250 shares
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6250 usd
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66593750 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66593750 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66593750 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66593750 shares
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
45243 usd
CY2024Q2 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
9501 usd
CY2024Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1440 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
45243 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38384 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
45243 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
38384 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1440 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4646 usd
CY2024Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1440 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-4646 usd
CY2024Q2 us-gaap Other Income Tax Expense Benefit Continuing Operations
OtherIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2023 us-gaap Other Income Tax Expense Benefit Continuing Operations
OtherIncomeTaxExpenseBenefitContinuingOperations
0 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001096906-24-001373-index-headers.html Edgar Link pending
0001096906-24-001373-index.html Edgar Link pending
0001096906-24-001373.txt Edgar Link pending
0001096906-24-001373-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gdlg-20240430.htm Edgar Link pending
gdlg-20240430.xsd Edgar Link pending
gdlg_ex31z1.htm Edgar Link pending
gdlg_ex31z2.htm Edgar Link pending
gdlg_ex32z1.htm Edgar Link pending
gdlg_ex32z2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
gdlg-20240430_cal.xml Edgar Link unprocessable
gdlg-20240430_def.xml Edgar Link unprocessable
gdlg-20240430_lab.xml Edgar Link unprocessable
gdlg-20240430_pre.xml Edgar Link unprocessable
gdlg-20240430_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending